Weight-loss drugs like Ozempic, developed by Novo Nordisk, have been shown in a new study to potentially reduce rates of opioid and alcohol abuse by up to 50%. The study suggests that these medications may provide additional benefits beyond weight loss and diabetes management, offering hope for addressing substance abuse issues. This research supports the idea that weight-loss drugs could play a significant role in improving overall health outcomes beyond their primary intended use.
Full Article
Are You One of the Millions of People Afraid of Investing in Cryptocurrency? Here Are 3 Ways to Invest in Crypto That Will Let You Sleep at Night.
Bitcoin has surged over 1,060% in the last five years but has faced significant drawdowns exceeding 80%, contributing to 63% of U.S. adults expressing low confidence in cryptocurrencies as a safe investment. Despite this skepticism, a Motley Fool report indicates that 20% of American adults own crypto, with 42% planning to invest within the next year. Need More Context? 🔎
Read more